| |
|
|
TRIMprob
Galileo Avionica, a Finmeccanica Company focused on defence
electronics, following a discovery by the physicist Dr. Clarbruno Vedruccio,
has applied advanced military technologies to develop a portable
electro-medical device for non invasive diagnostics called TRIMprob (Tissue
Resonance InterferoMeter Probe), which can detect in real time and at an early
stage various disorders from inflammatory conditions to cancers.
The device is user friendly and analyses the patient fully dressed
and with no discomfort.
The device is made of a thin probe about 30 cm long, powered by
batteries and of a receiver. A specific software entirely elaborated by Galileo
Avionica acquires, reads and manages the diagnostic data.
The TRIMprob emits a beam of coherent electromagnetic waves at very
low power which tunes on the specific frequencies of the examined structures.
When the electromagnetic field hits a biologically altered tissue, a phenomenon
of interference with the analysed structure takes place.
This phenomenon is interpreted by specific algorithms, and allows
the detection of cancer and other pathologies: vascular disorders, joint and
bone diseases, sinew and muscle injuries, inflammatory conditions, fibromas.
Developed entirely in Italy, the equipment is based on the HSM
technology (Hybrid State Maser) discovered by Clarbruno Vedruccio, who had at
first developed a certain number of prototypes, before teaming with Galileo
Avionica – who has acquired exploitation rights – to produce a marketable
product. This technology generates highly coherent space and time
electromagnetic fields and through miniaturized sensors, interacts
microscopically with the “organic substance” under examination.
The Electromagnetism Laboratory of Galileo Avionica in Turin, which
has perfected the TRIMprob, has over thirty years of experience and world
recognition of excellence, working closely with Universities, civil and
military Research Centers.
The HSM technology offers also significant prospects in the military
field where it is proving effective in detecting buried explosives.
In fact Dr. Vedruccio had at first begun his studies seeking, with a
self produced probe, non homogeneities in the soil, to detect the presence
under the ground of non metallic mines. During laboratory experiments he noted
and investigated the interference of this probe with live “biological
substances” and consequently pursued his studies until the development of a
demonstrator.
Today the TRIMprob is an impressive diagnostic device that can supply real
time information on the condition of human tissues and organs.
To certify the diagnosis validity of TRIMprob, a certain number of clinical
experiments have been carried out by highly qualified Italian hospitals, with
specific regard to cancer detection in prostate, breast and stomach. The
studies have reached extremely good results, now available, in terms of
sensitivity, accuracy and specificity of the device.
Other experiments are under way on lung and liver and further ones will be
initiated shortly on thyroids, uterus, pancreas and heart diseases.
Marketing of the prostate TRIMprob, is expected for the summer of 2003. |
